ClavystBio — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

SunBird Biosunbirdbio.comOct 2024

Biotechnology company developing blood-based diagnostic tests for neurological disorders and early-stage cancer.

Cambridge, US

Co-investorsAlumni Ventures ARCH Venture Partners Polaris Partners S32

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.